|
1
|
Saeedi P, Petersohn I, Salpea P, Malanda
B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA,
Ogurtsova K, et al: Global and regional diabetes prevalence
estimates for 2019 and projections for 2030 and 2045: Results from
the International diabetes federation diabetes atlas, 9th edition.
Diabetes Res Clin Pract. 157(107843)2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
International Diabetes Federation: IDF
diabetes atlas. 10th edition. International Diabetes Federation,
Brussels, 2021.
|
|
3
|
American Diabetes Association. Economic
costs of diabetes in the U.S. in 2017. Diabetes Care. 41:917–928.
2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
International Diabetes Federation: IDF
diabetes atlas. 8th edition. International Diabetes Federation,
Brussels, 2017.
|
|
5
|
Handsaker JC, Brown SJ, Bowling FL,
Maganaris CN, Boulton AJ and Reeves ND: Resistance exercise
training increases lower limb speed of strength generation during
stair ascent and descent in people with diabetic peripheral
neuropathy. Diabet Med. 33:97–104. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Tzeng YS, Deng SC, Wang CH, Tsai JC, Chen
TM and Burnouf T: Treatment of nonhealing diabetic lower extremity
ulcers with skin graft and autologous platelet gel: A case series.
Biomed Res Int. 2013(837620)2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Lipsky BA, Aragón-Sánchez J, Diggle M,
Embil J, Kono S, Lavery L, Senneville É, Urbančič-Rovan V and Van
Asten S: International Working Group on the Diabetic Foot. Peters
EJ: IWGDF guidance on the diagnosis and management of foot
infections in persons with diabetes. Diabetes Metab Res Rev. 32
(Suppl 1):S45–S74. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Driver VR, Hanft J, Fylling CP and Beriou
JM: Autologel Diabetic Foot Ulcer Study Group. A prospective,
randomized, controlled trial of autologous platelet-rich plasma gel
for the treatment of diabetic foot ulcers. Ostomy Wound Manage.
52:68–70, 72, 74. 2006.PubMed/NCBI
|
|
9
|
Willrich A, Pinzur M, McNeil M, Juknelis D
and Lavery L: Health related quality of life, cognitive function,
and depression in diabetic patients with foot ulcer or amputation.
A preliminary study. Foot Ankle Int. 26:128–134. 2005.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Piccin A, Di Pierro AM, Canzian L,
Primerano M, Corvetta D, Negri G, Mazzoleni G, Gastl G, Steurer M,
Gentilini I, et al: Platelet gel: A new therapeutic tool with great
potential. Blood Transfus. 15:333–340. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Natarajan S, Williamson D, Stiltz D and
Harding K: Advances in wound care and healing technology. Am J Clin
Dermatol. 1:269–275. 2000.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Creager MA, White CJ, Hiatt WR, Criqui MH,
Josephs SC, Alberts MJ, Pearce WH, Gray BH and Rocha-Singh KJ:
American Heart Association. Atherosclerotic peripheral vascular
disease symposium II: Executive summary. Circulation.
118:2811–2825. 2008.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ankle Brachial Index Collaboration. Fowkes
FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, Folsom
AR, Hirsch AT, Dramaix M, et al: Ankle-brachial index combined with
Framingham risk score to predict cardiovascular events and
mortality: A meta-analysis. JAMA. 300:197–208. 2008.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Marso SP and Hiatt WR: Peripheral arterial
disease in patients with diabetes. J Am Coll Cardiol. 47:921–929.
2006.PubMed/NCBI View Article : Google Scholar
|
|
15
|
del Mar Roca M, Sanlaureano C, Nieto GB,
Sánchez C, Valencia I and Diosdado MA: Evaluación del a enfermedad
vascular periférica en pacientes con diabetes tipo 2 mediante
medición del índice tobillo-brazo. Av Diabetol. 23:370–374.
2007.
|
|
16
|
Schaper NC, Andros G, Apelqvist J, Bakker
K, Lammer J, Lepantalo M, Mills JL, Reekers J, Shearman CP, Zierler
RE, et al: Specific guidelines for the diagnosis and treatment of
peripheral arterial disease in a patient with diabetes and
ulceration of the foot 2011. Diabetes Metab Res Rev. 28 (Suppl
1):S236–S237. 2012.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Beckert S, Witte M, Wicke C, Königsrainer
A and Coerper S: A new wound-based severity score for diabetic foot
ulcers: A prospective analysis of 1,000 patients. Diabetes Care.
29:988–992. 2006.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Tomita M, Kabeya Y, Okisugi M, Katsuki T,
Oikawa Y, Atsumi Y, Matsuoka K and Shimada A: Diabetic
microangiopathy is an independent predictor of incident diabetic
foot ulcer. J Diabetes Res. 2016(5938540)2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Steed DL, Attinger C, Colaizzi T,
Crossland M, Franz M, Harkless L, Johnson A, Moosa H, Robson M,
Serena T, et al: Guidelines for the treatment of diabetic ulcers.
Wound Repair Regen. 14:680–692. 2006.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Lone AM, Zaroo MI, Laway BA, Pala NA,
Bashir SA and Rasool A: Vacuum-assisted closure versus conventional
dressings in the management of diabetic foot ulcers: A prospective
case-control study. Diabet Foot Ankle.
5(10.3402/dfa.v5.23345)2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Polak A, Franek A and Taradaj J:
High-voltage pulsed current electrical stimulation in wound
treatment. Adv Wound Care (New Rochelle). 3:104–117.
2014.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Stoekenbroek RM, Santema TB, Legemate DA,
Ubbink DT, van den Brink A and Koelemay MJ: Hyperbaric oxygen for
the treatment of diabetic foot ulcers: A systematic review. Eur J
Vasc Endovasc Surg. 47:647–655. 2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Sclafani AP and Azzi J: Platelet
preparations for use in facial rejuvenation and wound healing: A
critical review of current literature. Aesthetic Plast Surg.
39:495–505. 2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Carter CA, Jolly DG, Worden CE Sr, Hendren
DG and Kane CJ: Platelet-rich plasma gel promotes differentiation
and regeneration during equine wound healing. Exp Mol Pathol.
74:244–255. 2003.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zhang J, Li Y, Li H, Zhu B, Wang L, Guo B,
Xiang L, Dong J, Liu M and Xiang G: GDF11 improves angiogenic
function of EPCs in diabetic limb ischemia. Diabetes. 67:2084–2095.
2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
McCarrel TM, Minas T and Fortier LA:
Optimization of leukocyte concentration on platelet-rich plasma for
the treatment of tendinopathy. J Bone Joint Surg Am.
94(e143(1-8))2012.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Alves R and Grimalt R: A review of
platelet-rich plasma: History, biology, mechanism of action, and
classification. Skin Appendage Disord. 4:18–24. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Andia I, Rubio-Azpeitia E, Martin JI and
Abate M: Current concepts and translational uses of platelet-rich
plasma biotechnology. In: Ekinci D (ed). Biotechnology. eBook:
InTechOpen, 2015.
|
|
29
|
Piccin A, Di Pierro AM, Tagnin M, Russo C,
Fustos R, Corvetta D, Primerano M, Magri E, Conci V, Gentilini I,
et al: Healing of soft tissue wound of the neck and jaw
osteoradionecrosis using platelet gel. Regen Med. 11:459–463.
2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Ye F, Li H, Qiao G, Chen F, Tao H, Ji A
and Hu Y: Platelet-rich plasma gel in combination with Schwann
cells for repair of sciatic nerve injury. Neural Regen Res.
7:2286–2292. 2012.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Caramella CM, Sandri G, Rossi S, Mori M,
Cristina Bonferoni M, Ferrari F, Del Fante C and Perotti C: New
therapeutic platforms for the treatment of epithelial and cutaneous
lesions. Curr Drug Deliv. 10:18–31. 2013.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Kuffler DP: Platelet-rich plasma and the
elimination of neuropathic pain. Mol Neurobiol. 48:315–332.
2013.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Kuffler DP: Platelet-rich plasma promotes
axon regeneration, wound healing, and pain reduction: Fact or
fiction. Mol Neurobiol. 52:990–1014. 2015.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Dohan Ehrenfest DM, Bielecki T, Mishra A,
Borzini P, Inchingolo F, Sammartino G, Rasmusson L and Everts PA:
In search of a consensus terminology in the field of platelet
concentrates for surgical use: Platelet-rich plasma (PRP),
platelet-rich fibrin (PRF), fibrin gel polymerization and
leukocytes. Curr Pharm Biotechnol. 13:1131–1137. 2012.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Marx RE: Platelet-rich plasma (PRP): What
is PRP and what is not PRP? Implant Dent. 10:225–228. 2001.
|
|
36
|
Moojen DJ, Everts PA, Schure RM,
Overdevest EP, van Zundert A, Knape JT, Castelein RM, Creemers LB
and Dhert WJ: Antimicrobial activity of platelet-leukocyte gel
against Staphylococcus aureus. J Orthop Res. 26:404–410.
2008.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Dohan Ehrenfest DM, Bielecki T, Jimbo R,
Barbé G, Del Corso M, Inchingolo F and Sammartino G: Do the fibrin
architecture and leukocyte content influence the growth factor
release of platelet concentrates? An evidence-based answer
comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte-
and platelet-rich fibrin (L-PRF). Curr Pharm Biotechnol.
13:1145–1152. 2012.PubMed/NCBI View Article : Google Scholar
|
|
38
|
U.S. Food and Drug Administration (FDA):
Regulatory considerations for human cells, tissues and cellular and
tissue-based products: Minimal manipulation and homologous use. US
Department of Health and Human Services, Maryland, 2017.
|
|
39
|
Rachita D and Sukesh MS: Principles and
methods of preparation of platelet-rich plasma: A review and
author's perspective. J Cutan Aesthet Surg. 7:189–197.
2014.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Harrison S, Vavken P, Kevy S, Jacobson M,
Zurakowski D and Murray MM: Platelet activation by collagen
provides sustained release of anabolic cytokines. Am J Sports Med.
39:729–734. 2011.PubMed/NCBI View Article : Google Scholar
|
|
41
|
De Pascale MR, Sommese L, Casamassimi A
and Napoli C: Platelet derivatives in regenerative medicine: An
update. Transfus Med Rev. 29:52–61. 2015.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Wagner FW Jr: The dyvascular foot: A
system for diagnosis and treatment. Foot Ankle. 2:64–122.
1981.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Schaper NC, van Netten JJ, Apelqvist J,
Bus SA, Hinchliffe RJ and Lipsky BA: IWGDF Editorial Board.
Practical Guidelines on the prevention and management of diabetic
foot disease (IWGDF 2019 update). Diabetes Metab Res Rev. 36 (Suppl
1)(e3266)2020.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Saldalamacchia G, Lapice E, Cuomo V, De
Feo E, D'Agostino E, Rivellese AA and Vaccaro O: A controlled study
of the use of autologous platelet gel for the treatment of diabetic
foot ulcers. Nutr Metab Cardiovasc Dis. 14:395–396. 2004.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Li L, Chen D, Wang C, Yuan N, Wang Y, He
L, Yang Y, Chen L, Liu G, Li X and Ran X: Autologous platelet-rich
gel for treatment of diabetic chronic refractory cutaneous ulcers:
A prospective, randomized clinical trial. Wound Repair Regen.
23:495–505. 2015.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Kontopodis N, Tavlas E, Papadopoulos G,
Pantidis D, Kafetzakis A, Chalkiadakis G and Ioannou C:
Effectiveness of platelet-rich plasma to enhance healing of
diabetic foot ulcers in patients with concomitant peripheral
arterial disease and critical limb ischemia. Int J Low Extrem
Wounds. 15:45–51. 2016.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Ahmed M, Reffat SA, Hassan A and Eskander
F: Platelet-rich plasma for the treatment of clean diabetic foot
ulcers. Ann Vasc Surg. 38:206–211. 2017.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Goda A, Metwally M, Ewada A and Hossam E:
Platelet-rich plasma for the treatment of diabetic foot ulcer a
randomized, double-blind study. Egypt J Surg. 37:178–184. 2018.
|
|
49
|
Abd El-Mabood ESA and Ali HE:
Platelet-rich plasma versus conventional dressing does this really
affect diabetic foot wound-healing outcomes? Egypt J Surg.
37:16–26. 2018.
|
|
50
|
Gude W, Hagan D, Abood F and Clausen P:
Aurix gel is an effective intervention for chronic diabetic foot
ulcers: A pragmatic randomized controlled trial. Adv Skin Wound
Care. 32:416–426. 2019.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Liao X, Liang JX, Li SH, Huang S, Yan JX,
Xiao LL, Song JX and Liu HW: Allogenic platelet-rich plasma therapy
as an effective and safe adjuvant method for chronic wounds. J Surg
Res. 246:284–291. 2020.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Elsaid A, El-Said M, Emile S, Youssef M,
Khafagy W and Elshobaky A: Randomized controlled trial on
autologous platelet-rich plasma versus saline dressing in treatment
of non-healing diabetic foot ulcers. World J Surg. 44:1294–1301.
2020.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Ullah A, Jawaid SI, Qureshi PNAA, Siddiqui
T, Nasim K, Kumar K, Ullah S, Sajjad Cheema M, Kumari N and Elias
HA: Effectiveness of injected platelet-rich plasma in the treatment
of diabetic foot ulcer disease. Cureus. 14(e28292)2022.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Ahmed OME, Nageeb RM, Rizk MAMAE and Boles
BNS: A comparative study between vacuum-assisted closure (VAC)
versus platelets rich plasma (PRP) for dressing of diabetic foot
ulcers. QJM Int J Med. 117(hcae070.220)2024.
|
|
55
|
Malekpour Alamdari N, Shafiee A,
Mirmohseni A and Besharat S: Evaluation of the efficacy of
platelet-rich plasma on healing of clean diabetic foot ulcers: A
randomized clinical trial in Tehran, Iran. Diabetes Metab Syndr.
15:621–626. 2021.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Shao S, Pan R and Chen Y: Autologous
platelet-rich plasma for diabetic foot ulcer. Trends Endocrinol
Metab. 31:885–890. 2020.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Akingboye AA, Giddins S, Gamston P, Tucker
A, Navsaria H and Kyriakides C: Application of autologous derived
platelet-rich plasma gel in the treatment of chronic wound ulcer:
Diabetic foot ulcer. J Extra Corpor Technol. 42:20–29.
2010.PubMed/NCBI
|
|
58
|
Kakudo N, Kushida S, Minakata T, Suzuki K
and Kusumoto K: Platelet-rich plasma promotes epithelialization and
angiogenesis in a splitthickness skin graft donor site. Med Mol
Morphol. 44:233–236. 2011.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Martinez-Zapata MJ, Martí-Carvajal AJ,
Solà I, Expósito JA, Bolíbar I, Rodríguez L, Garcia J and Zaror C:
Autologous platelet-rich plasma for treating chronic wounds.
Cochrane Database Syst Rev. 2016(CD006899)2016.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Villela DL and Santos VLCG: Evidence on
the use of platelet-rich plasma for diabetic ulcer: A systematic
review. Growth Factors. 28:111–116. 2010.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Carter MJ, Fylling CP and Parnell LKS: Use
of platelet rich plasma gel on wound healing: A systematic review
and meta-analysis. Eplasty. 11(e38)2011.PubMed/NCBI
|
|
62
|
Huang S, Li Q, Li X, Ye H, Zhang L and Zhu
X: Recent research progress of wound healing biomaterials
containing platelet-rich plasma. Int J Nanomedicine. 20:3961–3976.
2025.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Martinez-Zapata MJ, Martí-Carvajal AJ,
Solà I, Expósito JA, Bolíbar I, Rodríguez L and Garcia J:
Autologous platelet-rich plasma for treating chronic wounds.
Cochrane Database Syst Rev. 10(CD006899)2012.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Meznerics FA, Fehérvári P, Dembrovszky F,
Kovács KD, Kemény LV, Csupor D, Hegyi P and Bánvölgyi A:
Platelet-rich plasma in chronic wound management: A systematic
review and meta-analysis of randomized clinical trials. J Clin Med.
11(7532)2022.PubMed/NCBI View Article : Google Scholar
|
